BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6968392)

  • 1. Numerical changes in T cell subsets (T gamma and T mu) in leprosy patients.
    Izumi S; Sugiyama K; Matsumoto Y; Nagai T
    Microbiol Immunol; 1980; 24(8):733-40. PubMed ID: 6968392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakdown product of factor B as an index of complement activation in lepromatous leprosy and its relation with bacillary load.
    Saha K; Sharma V; Chakrabarty AK; Sehgal VN
    Scand J Immunol; 1983 Jan; 17(1):37-43. PubMed ID: 6342123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
    Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
    Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
    Saha K; Chakraborty AK; Sharma V; Sehgal VN
    Lepr Rev; 1982 Dec; 53(4):253-60. PubMed ID: 6984124
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B; Barnetson RS; Kronvall G; Zubler RH; Lambert PH
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphonuclear cell function in the various polar types of leprosy and erythema nodosum leprosum.
    Sher R; Anderson R; Glover A; Wadee AA
    Infect Immun; 1978 Sep; 21(3):959-65. PubMed ID: 711343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
    Beuria MK; Mohanty KK; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood T lymphocyte subsets in leprosy.
    Rea TH; Bakke AC; Parker JW; Modlin RL; Horwitz DA
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):311-7. PubMed ID: 6332790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
    Bansal F; Narang T; Dogra S; Vinay K; Chhabra S
    Indian J Dermatol Venereol Leprol; 2018; 84(5):573-577. PubMed ID: 28656911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.
    de Messias IJ; Santamaria J; Brenden M; Reis A; Mauff G
    Clin Exp Immunol; 1993 May; 92(2):284-7. PubMed ID: 8485914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
    Lim SD; Kiszkiss DF; Jacobson RR; Choi YS; Good RA
    Infect Immun; 1974 Feb; 9(2):394-9. PubMed ID: 4544619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.